Rayno Life Science Portfolio 2017

Update-1 6/27/17 With the XBI up 34% YTD at $79.34, take a little off for future trades.

=====

Rayno Life Science Portfolio 2017 YTD 6/15

  • Top winners YTD: BLUE up 78.9%,FMI up 121.5%,RHHBY up 13%, ABBV up 12.7%.
  • Top Losers YTD: GILD down 9.5%, BMY down 7%.
  • XBI up 20.9%, our top pick for aggressive portfolios. More volatile than the IBB.
  • Portfolio mix of large cap dividend with smaller cap growth and niche plays.
Company Ticker Date Price Price Perf Price YTD ’17
Started 4/25 % 6/15/17 %  Dividend %
Rayno Picks
Abbvie ABBV 2/3/16 56.5 65.45 16 70.6 12.74  3.61
Amgen AMGN 9/12/16 172 165 -4 164.1 12.24  2.83
bluebird bio BLUE 2/3/16 43.75 88.1 103 110.4 78.9  –
Bristol Myers BMY 2/16/16 61 54.2 -7.7 54.28 -7.12  2.89
Foundation Med FMI 7/5/16 20.4 34 68 39.2 121.5  –
Hologic HOLX 12/20/16 40 44.4 10.1 44.72 11.5  –
Gilead Sci GILD 2/3/16 85.8 67.3 -20.9 64.81 -9.5  3.25
Roche ADR RHHBY 4/4/16 30.36 32.4 7.9 32.22 13  3.16
IBB 6/29/16 250 296 18.4 293.8 10.7
XBI 1/31/17 64 70.7 9.4 71.55 20.9
QQQ n/a 135.13 n/a 139.1 17.4

, , , , ,

No comments yet.

Leave a Reply